- Home
- BATL vs HBIO Comparison
BATL vs HBIO Comparison
Compare BATL & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BATL
- HBIO
- Stock Information
- Founded
- BATL 1987
- HBIO 1901
- Country
- BATL United States
- HBIO United States
- Employees
- BATL N/A
- HBIO N/A
- Industry
- BATL Oil & Gas Production
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- BATL Energy
- HBIO Industrials
- Exchange
- BATL Nasdaq
- HBIO Nasdaq
- Market Cap
- BATL 21.2M
- HBIO 24.6M
- IPO Year
- BATL N/A
- HBIO 2000
- Fundamental
- Price
- BATL $1.12
- HBIO $0.62
- Analyst Decision
- BATL
- HBIO Buy
- Analyst Count
- BATL 0
- HBIO 3
- Target Price
- BATL N/A
- HBIO $2.50
- AVG Volume (30 Days)
- BATL 441.2K
- HBIO 18.5M
- Earning Date
- BATL 11-13-2025
- HBIO 11-06-2025
- Dividend Yield
- BATL N/A
- HBIO N/A
- EPS Growth
- BATL N/A
- HBIO N/A
- EPS
- BATL N/A
- HBIO N/A
- Revenue
- BATL $185,206,000.00
- HBIO $87,371,000.00
- Revenue This Year
- BATL N/A
- HBIO N/A
- Revenue Next Year
- BATL N/A
- HBIO $7.02
- P/E Ratio
- BATL N/A
- HBIO N/A
- Revenue Growth
- BATL N/A
- HBIO N/A
- 52 Week Low
- BATL $1.00
- HBIO $0.28
- 52 Week High
- BATL $6.84
- HBIO $2.61
- Technical
- Relative Strength Index (RSI)
- BATL 47.55
- HBIO 63.78
- Support Level
- BATL $1.09
- HBIO $0.49
- Resistance Level
- BATL $1.11
- HBIO $0.65
- Average True Range (ATR)
- BATL 0.09
- HBIO 0.09
- MACD
- BATL -0.01
- HBIO 0.01
- Stochastic Oscillator
- BATL 13.07
- HBIO 40.57
About BATL Battalion Oil Corporation
Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.